Product Description
Cranbkon Tablets contain D-Mannose 300 mg + Cranberry Extract 200 mg + Potassium Magnesium Citrate 987 mg. They combine D-mannose, a urinary tract support formulation, with potassium magnesium citrate, a urinary alkaliser. Available from Pharmakon Lifesciences, Karnal, for PCD franchise and third-party manufacturing.
Indications
Support in recurrent urinary tract infections
Burning urination
Prevention of kidney stones (urine alkalinisation)
Dosage
As directed by the physician or dietitian. Do not exceed the recommended dose.
Side Effects
Generally well tolerated; mild stomach upset may occur. Do not exceed the recommended dose.
Storage Instructions
Store in a cool, dry place below 30°C, protected from light and moisture.
Keep out of the reach of children.
Availability
Cranbkon Tablets is available for PCD Pharma Franchise distribution and Third-Party Contract Manufacturing across India. Reach out to the manufacturer for pricing, MOQ and territory details.
Pharmaceutical Specifications
| Product Name | Cranbkon Tablets |
| Dosage Form | Tablet |
| Composition | D-Mannose 300 mg + Cranberry Extract 200 mg + Potassium Magnesium Citrate 987 mg |
| Strength | N/A |
| Packing | 10x1x10 Alu-Alu (Mono Carton) |
| MRP | On Request |
| Prescription | OTC (Non-Schedule) |
| Manufactured by | Pharmakon Lifesciences, Karnal |
| Delivery Time | 15–25 working days |
| Certifications | ISO 9001:2015 · WHO-GMP · Verified Company |
Company Information
Pharmakon Lifesciences
Karnal-based pharma company offering PCD franchise and third-party manufacturing in neuro, derma, gynae, ortho, dental and paediatric ranges. Operating since 2018.
